Induced septal infarction as an alternative therapeutic strategy for hypertrophic obstructive cardiomyopathy: New observations derived from one case;Inducción de infarto septal como alternativa terapéutica en la miocardiopatía hipertrófica obstructiva: Nuevas observaciones a propósito de un caso

Revista Espanola de Cardiologia

Volumn 52, Issue 5, 1999, Pages 339-342

  De la Torre Hernández, José Maria ^a   Mata, Nuria Sánchez ^a   Riesco, Francisco Riesco ^a   Delgado, Blanca Ruiz ^a   Azcárate, Alberto Ochoteco ^a   Gil, Javier Zueco ^a   Dejean, Thierry Colman ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Catheter ablation; Hypertrophic obstructive cardiomyopathy; Infarction

Indexed keywords

ALCOHOL;

ARTIFICIAL EMBOLISM; CASE REPORT; FOLLOW UP; HEART CATHETERIZATION; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFARCTION; MALE; METHODOLOGY; MIDDLE AGED; REVIEW;

CARDIOMYOPATHY, HYPERTROPHIC; EMBOLIZATION, THERAPEUTIC; ETHANOL; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTUM; HUMANS; INFARCTION; MALE; MIDDLE AGED; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0033127870     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)74924-9     Document Type: Article

References (8)

1. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92: 1.680-1.692.
2. Gietzen F, Leuner C, Gerenkamp T, Kuhn H. Relief of obstruction in hypertrophie cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery. Eur Heart J 1994; 15: 125.
3. Sigwart U. Non-surgical myocardial reduction for hypertrophie obstructive cardiomyopathy. Lancet 1995; 346: 211-214.
4. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D et al. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1997; 95: 2.075-2.081.
5. Boekstegers P, Steinbigler P. Comparison of AV-sequential pacing and transcoronary myocardial ablation (TASH-procedure) in the treatment of hypertrophie obstructive cardiomyopathy. Circulation 1997; 96(Supl 1): 217.
6. Lakkis NM, Kleiman NS, Killip DM, Spencer WH. Ethanol septal reduction for symptomatic hypertrophie cardiomyopathy. Circulation 1997; 96(Supl 1): 218.
7. Seggewiss H, Faber L, Gleichmann U, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophie obstructive cardiomyopathy (HOCM): acute hemodynamic and clinical results. Circulation 1997; 96 (Supl 1): 218.
8. Braunwald E. Induced septal infarction. A new therapeutic strategy for hypertrophie obstructive cardiomyopathy. Circulation 1997; 95: 1.981-1.982.